Catalyst

Slingshot members are tracking this event:

Roche’s Gazyvaro approved in Europe in combination with bendamustine for people with previously treated follicular lymphoma

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
RHHBY

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 16, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Gazyvaro, Obinutuzumab, Phase Iii Gadolin Study, Bendamustine